Here are the biggest unknowns the DealBook team will be watching as we cover business and the economy this year.
Many shots seem to have “off-target” benefits, such as lowering the risk of dementia, studies have found.
Steep import taxes have raised prices and affected U.S. businesses, but not quite as much as expected. A new report offers some reasons.
They drew with crayons, possibly fed on maggots and maybe even kissed us: Forty millenniums later, our ancient human cousins continued to make news.
As the new year begins, savings have hit unprecedented levels, but rising health care costs and growing poverty make retirement unaffordable for many.
Karen Budd-Falen, the No. 3 at the Interior Department, didn’t disclose a $3.5 million water-rights contract between her husband and the developers of a Nevada mine, records show.
Jenelle Manzi started a nutrition company while performing with New York City Ballet. Now she’s doing her makeup in cabs and taking Zoom meetings as she sews pointe shoes.
After spending nearly $50 billion to expand the country’s Tengiz oil field, Chevron and its partners encounter more uncertainty.
The gray-market drugs flooding Silicon Valley reveal a community that believes it can move faster than the F.D.A.
The developers of Revolution Wind off Rhode Island and Empire Wind off New York are the latest to sue the Trump administration.
The boutique chain’s co-founder, Candace Nelson, said that the business had ceased operations at year’s end. It was sold to a private equity firm more than a decade ago.
Saks Global’s executive chairman, Richard Baker, is taking over the luxury retailer he created with the 2024 acquisition of Neiman Marcus and Bergdorf Goodman.
He was a founder of More, which skewered the foibles of the press in the 1970s, and later wrote a critical biography of the psychoanalyst Bruno Bettelheim.
Problems with a 25-year-old landmark paper on the safety of Roundup’s active ingredient, glyphosate, have led to calls for the E.P.A. to reassess the widely used chemical.